- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Durect (NASDAQ:DRRX), Quotes and News Summary
Durect (NASDAQ: DRRX)
Earnings
see more| FY 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-12-20 | ||||||
| REV | |||||||
| FY 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-11-09 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Durect Questions & Answers
You can purchase shares of Durect (NASDAQ: DRRX) through any online brokerage.
Other companies in Durect’s space includes: Satsuma Pharmaceuticals (NASDAQ:STSA), SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI), Anebulo Pharmaceuticals (NASDAQ:ANEB) and Endo International (NASDAQ:ENDP).
The latest price target for Durect (NASDAQ: DRRX) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting DRRX to rise to within 12 months (a possible 412.82% upside). 50 analyst firms have reported ratings in the last year.
The stock price for Durect (NASDAQ: DRRX) is $0.78 last updated August 12, 2022, 8:00 PM UTC.
The next Durect (DRRX) dividend date is projected to be Thursday, September 1, 2022.
Durect’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Durect.
Durect is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.